Skip to main content
. 2015 Nov 17;59(12):7723–7734. doi: 10.1128/AAC.01291-15

TABLE 4.

Isolates temporally collected from a single patient

Organism Isolate Date collected Source Imipenem MICa blaKPC PCR
E. cloacae MNCRE41 March 10 Sputum 8, R +
E. coli MNCRE46 April 11 Urine 2, I; 4, R (ms) +
E. coli MNCRE47 April 11 Sputum ≤1, S
E. coli MNCRE45 April 11 Urine ≥16, R +
E. coli MNCRE44 April 13 Sputum ≤1, S (≥16, Rb) +
E. cloacae MNCRE51 May 1 Sputum 8, R +
a

MIC values (in micrograms per milliliter) were reported by the submitting clinical laboratories using Vitek 2 (bioMérieux) automated susceptibility analysis, with the exception of the entry labeled ms, which represents a MicroScan (Siemens Healthcare Diagnostics) automated susceptibility testing result. Letters after numbers indicate resistance status: R, resistant; I, intermediate; S, susceptible.

b

Due to the initial carbapenem-susceptible result in an otherwise highly drug-resistant MIC profile, isolate MNCRE44 was retested using broth microdilution to confirm a carbapenem-resistant phenotype.

HHS Vulnerability Disclosure